Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10232-10241
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Figure 3 Overall and relapse-free survival.
A: The overall survival rate of 65 patients was compared using Cox proportional hazards analysis. Although there was no significant difference, the overall survival rate of the patients with more than 5 CTCs was lower than that of patients with 5 or less CTCs (hazard ratio, 2.07; 95%CI: 0.693-5.744; P = 0.183); B: The relapse-free survival rates of 57 patients with different CTC levels who underwent curative surgery were compared using Cox proportional hazards analysis. Relapse-free survival was significantly lower in patients with more than 5 CTCs (hazard ratio, 2.28; 95% CI: 0.068-4.698; P = 0.034). CTCs: Circulating tumour cells.
- Citation: Ito H, Sato J, Tsujino Y, Yamaguchi N, Kimura S, Gohda K, Murakami K, Onimaru M, Ohmori T, Ishikawa F, Inoue H. Long-term prognostic impact of circulating tumour cells in gastric cancer patients. World J Gastroenterol 2016; 22(46): 10232-10241
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10232.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10232